Cantor Fitzgerald Reiterates Overweight on Affimed, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on Affimed (NASDAQ:AFMD) and maintained a $7 price target.
September 12, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on Affimed and maintained a $7 price target, indicating a positive outlook for the stock.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates that the firm believes Affimed's stock will outperform the market in the near future. The maintenance of a $7 price target suggests that the firm believes the stock is currently undervalued. This could lead to increased investor interest and a potential rise in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100